Home›Stock Screener›Zydus Life Science›Quarterly Results

Zydus Life Science Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹1,341 Cr
QMar 2026
Quarterly Results

In Mar 2026, Zydus Life Science (ZYDUSLIFE) reported revenue ₹7,569 Cr and net profit ₹1,341 Cr — revenue +18.8% YoY. Compare with ZYDUSLIFE fair value to assess whether the stock is under or overvalued.

ZYDUSLIFE Quarterly Results — Revenue, Profit & EPS Highlights

Zydus Life Science latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore ZYDUSLIFE price movement history to track price trends across different timeframes.

  • Revenue of ₹7,569 Cr in Mar 2026 (+23.1% vs Sept 2025, +18.8% vs Mar 2025)
  • Net Profit of ₹1,341 Cr in Mar 2026 (+8.2% vs Sept 2025, +7.8% vs Mar 2025)
  • EBITDA of ₹2,139 Cr in Mar 2026 (+6.7% vs Sept 2025)
  • Operating Margin of 27.0% in Mar 2026 (-4.0pp vs Sept 2025)
  • Earnings Per Share of ₹12.65 in Mar 2026 (+1.1% vs Sept 2025)

Zydus Life Science Quarterly Results — Revenue, EBITDA, Net Profit & EPS

ZYDUSLIFE quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Sept 2025 Mar 2025 Jun 2025 Dec 2025 QoQ YoY
Revenue (₹ Cr) 7,569 6,147 6,371 6,622 6,892 23.1% 18.8%
Net Profit (₹ Cr) 1,341 1,239 1,244 1,521 1,023 - -
EBITDA (₹ Cr) 2,139 2,005 1,749 2,137 1,759 - -
EPS (₹) 12.65 12.51 11.64 14.58 10.36 - -
Operating Margin (%) 27.0% 31.0% 27.0% 31.0% 24.0% - -

ZYDUSLIFE Share Price Trend — 1-Year Movement Across Quarterly Results

Zydus Life Science 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Zydus Life Science screener.

Profitability Ratios

Profit Margin 17.7%
EBITDA Margin 28.3%
Operating Margin 27.0%
ROE (Annual) 19.8%

Balance Sheet Highlights

Total Assets ₹52,407 Cr
Total Equity ₹27,111 Cr
Current Assets ₹19,906 Cr
Current Liabilities ₹7,113 Cr

Cash Flow Analysis

Operating Cash Flow ₹6,777 Cr
Investing Cash Flow ₹-8,377 Cr
Financing Cash Flow ₹2,014 Cr
Net Cash Flow ₹414 Cr

Current Market Data

Current Price ₹1085.80
Exchange NSE
Last Updated May 27, 2026

Revenue Trend (₹ Cr)

Jun 2025 6,622
Mar 2025 6,371
Sept 2025 6,147
Mar 2026 7,569

Net Profit Trend (₹ Cr)

Jun 2025 1,521
Mar 2025 1,244
Sept 2025 1,239
Mar 2026 1,341

Operating Margin Trend (%)

Jun 2025 31.0%
Mar 2025 27.0%
Sept 2025 31.0%
Mar 2026 27.0%

ZYDUSLIFE vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Zydus Life Science latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹442,581.33 Cr 1844.3 15,018 2,710 +1.0% +11.8% 18.0% 163.2
Divis Laboratories
Mar 2026 		₹179,363.85 Cr 6797.5 2,986 751 +4.4% +11.8% 25.2% 240.1
Torrent Pharmaceuti…
Mar 2026 		₹153,579.77 Cr 4537.8 4,111 364 +27.7% +42.2% 8.9% 394.2
Cipla
Mar 2026 		₹114,559.46 Cr 1418.2 6,612 543 -14.3% -4.0% 8.2% 206.4
Dr Reddys Laborator…
Mar 2026 		₹110,089.41 Cr 1319.0 7,996 221 -12.5% -11.5% 2.8% 497.7
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores